Thar's tendons in them thar valves!

Circulation Research

Volumn 103, Issue 9, 2008, Pages 914-915

  Benson, D Woodrow ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cardiac development; Cardiac valves; Valve disease

Indexed keywords

COLLAGEN TYPE 14; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NFAT; VASCULOTROPIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; COLLAGEN; SCX PROTEIN, MOUSE;

CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHORDA TENDINEA; EDITORIAL; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; HYPERTENSION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; TENDON; VALVE; ANIMAL; CELL LINEAGE; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; HEART VALVE; MESODERM; METABOLISM; MOUSE; MOUSE MUTANT; NOTE; ORGANOGENESIS; PRENATAL DEVELOPMENT; ULTRASTRUCTURE; VALVULAR HEART DISEASE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARTILAGE; CELL DIFFERENTIATION; CELL LINEAGE; COLLAGEN; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HEART VALVE DISEASES; HEART VALVES; MESODERM; MICE; MICE, KNOCKOUT; ORGANOGENESIS; TENDONS;

EID: 55449088099     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.187252     Document Type: Editorial

References (11)

1. Levay AK, Peacock JD, Lu Y, Koch M, Hinton RB Jr, Kadler KE, Lincoln Joy. Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circ Res. 2008;103:948-956.
2. Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, Lassar A, Tabin CJ. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development. 2001;128: 3855-3866.
3. Lincoln J, Lange AW, Yutzey KE. Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol. 2006;294:292-302.
4. Lincoln J, Alfieri CM, Yutzey KE. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev Biol. 2006;292:292-302.
5. Zhao B, Etter L, Hinton RB Jr, Benson DW. BMP and FGF regulatory pathways in semilunar valve precursor cells. Dev Dyn. 2007;236: 971-980.
6. Schoen FJ. Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. Cardiovasc Pathol. 2005;14:189-194.
7. Hinton RB Jr, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res. 2006;98:1431-1438.
8. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104:2525-2532.
9. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111:920-925.
10. Armstrong EJ, Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res. 2004;95:459-470.
11. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O?Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-e171.